OneSource Specialty Pharma Performance
- Today's Low
- ₹1,635
- Today's High
- ₹1,690
- 52 Week Low
- ₹1,057
- 52 Week High
- ₹2,027
- Open Price₹1,678
- Previous Close₹1,672
- Volume61,431
- 50 DMA₹1,659.80
- 100 DMA₹1,641.30
- 200 DMA₹1,636.80
OneSource Specialty Pharma Chart
Investment Returns
- Over 1 Month + 1.39%
- Over 3 Month + 1.63%
- Over 6 Month + 5.89%
- Over 1 Year -15.96%
Smart Investing Starts Here Start SIP with OneSource Specialty Pharma for Steady Growth!
OneSource Specialty Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -254.4
- PEG Ratio
- 0.8
- Market Cap Cr
- 18,775
- P/B Ratio
- 3.2
- Average True Range
- 72.1
- EPS
- -6.4
- Dividend Yield
- 0
- MACD Signal
- -2.7
- RSI
- 52.22
- MFI
- 39.54
Latest Stock News Updates
Intimation of Earnings Call to be held on July 25, 2026.
- BSE India
- 2 days 1 hour ago
Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2026 ,inter alia, to consider and approve Unaudited financial results (Standalone and Consolidated) for the quarter ended June 30, 2026.
- BSE India
- 2 days 19 hours ago
Under the agreement, OneSource will provide integrated Drug Substance and Drug Product manufacturing for Formycon's biosimilar programs from its biologics facility in Bangalore
- Business Line
- 1 week 2 days ago
OneSource Specialty Pharma Financials
OneSource Specialty Pharma Technicals
EMA & SMA
- Bearish Moving Average 11
- Bullish Moving Average 5
- 20 Day
- ₹1,654.40
- 50 Day
- ₹1,659.80
- 100 Day
- ₹1,641.30
- 200 Day
- ₹1,636.80
Resistance and Support
- R3 1,820.60
- R2 1,750.30
- R1 1,710.90
- S1 1,601.20
- S2 1,530.90
- S3 1,491.50
OneSource Specialty Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-07-24 | Quarterly Results | |
| 2026-05-13 | Audited Results | |
| 2026-01-23 | Quarterly Results | |
| 2025-11-11 | Quarterly Results | |
| 2025-08-04 | Quarterly Results |
About OneSource Specialty Pharma
OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations services across all phases of pre-clinical and clinical development and commercial supply of biologics. View More- NSE Symbol
- ONESOURCE
- BSE Symbol
- 544292
- Executive Director,Managing Director,Chief Executive Officer
- Neeraj Sharma
- ISIN
- INE013P01021
Similar Stocks to OneSource Specialty Pharma
Popular Stocks
OneSource Specialty Pharma FAQs
OneSource Specialty Pharma share price is ₹1,637 As on 23 July, 2026 | 13:26
The Market Cap of OneSource Specialty Pharma is ₹18774.9 Cr As on 23 July, 2026 | 13:26
The P/E ratio of OneSource Specialty Pharma is -254.4 As on 23 July, 2026 | 13:26
The PB ratio of OneSource Specialty Pharma is 3.2 As on 23 July, 2026 | 13:26
The 52 week High & Low of OneSource Specialty Pharma is ₹2026.5/₹1057 respectively As on 23 July, 2026 | 13:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.